271 related articles for article (PubMed ID: 32147383)
1. Risk of Mortality Associated With Atypical Antipsychotic use: A National Cohort Study of Older Adults With Depression and Parkinson's Disease.
Chekani F; Holmes HM; Johnson ML; Chen H; Sherer JT; Aparasu RR
Am J Geriatr Psychiatry; 2020 Oct; 28(10):1079-1088. PubMed ID: 32147383
[TBL] [Abstract][Full Text] [Related]
2. Risk of pneumonia associated with atypical antipsychotic use in nursing home residents with Parkinson's disease.
Chekani F; Holmes HM; Johnson ML; Chen H; Sherer JT; Aparasu RR
J Psychiatr Res; 2019 Oct; 117():116-121. PubMed ID: 31377483
[TBL] [Abstract][Full Text] [Related]
3. Use of Atypical Antipsychotics in Long-Term Care Residents with Parkinson's Disease and Comorbid Depression.
Chekani F; Holmes HM; Johnson ML; Chen H; Sherer JT; Aparasu RR
Drug Healthc Patient Saf; 2020; 12():23-30. PubMed ID: 32099480
[TBL] [Abstract][Full Text] [Related]
4. Atypical antipsychotic use and mortality risk in Parkinson disease.
Pham Nguyen TP; Thibault D; Hamedani AG; Weintraub D; Willis AW
Parkinsonism Relat Disord; 2022 Oct; 103():17-22. PubMed ID: 36027858
[TBL] [Abstract][Full Text] [Related]
5. Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study.
Layton JB; Forns J; McQuay LJ; Danysh HE; Dempsey C; Anthony MS; Turner ME
Drug Saf; 2023 Feb; 46(2):195-208. PubMed ID: 36517664
[TBL] [Abstract][Full Text] [Related]
6. Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysis.
Rajagopalan K; Rashid N; Doshi D
J Comp Eff Res; 2024 Jan; 13(1):e230114. PubMed ID: 38099518
[No Abstract] [Full Text] [Related]
7. Comparative Safety Signal Assessment of Hospitalization Associated With the Use of Atypical Antipsychotics.
Yunusa I; Teng C; Karaye IM; Crounse E; Alsahali S; Maleki N
Front Psychiatry; 2022; 13():917351. PubMed ID: 35733796
[TBL] [Abstract][Full Text] [Related]
8. Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.
Weintraub D; Chiang C; Kim HM; Wilkinson J; Marras C; Stanislawski B; Mamikonyan E; Kales HC
JAMA Neurol; 2016 May; 73(5):535-41. PubMed ID: 26999262
[TBL] [Abstract][Full Text] [Related]
9. Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data.
Niu X; Dennen S; Dembek C; Laubmeier K; Liu Y; Veeranki P; Tocco M; Williams GR
Curr Ther Res Clin Exp; 2021; 94():100629. PubMed ID: 34306269
[No Abstract] [Full Text] [Related]
10. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
11. Clearing the Fog: A Review of Antipsychotics for Parkinson's-Related Hallucinations: A Focus on Pimavanserin, Quetiapine and Clozapine.
Abdul-Rahman T; Herrera-Calderón RE; Aderinto N; Kundu M; Wireko AA; Adebusoye FT; Ekerin O; Lawal L; Mykolaivna NI; Alexiou A; Almashjary MN; Perveen A; Ashraf GM
J Integr Neurosci; 2024 Apr; 23(4):80. PubMed ID: 38682215
[TBL] [Abstract][Full Text] [Related]
12. Risk of Pneumonia is associated with Antipsychotic Drug Use among older patients with Parkinson's Disease: A Case-control Study.
Huang KH; Kuo WY; Kuan YH; Chang YC; Tsai TH; Lee CY
Int J Med Sci; 2021; 18(15):3565-3573. PubMed ID: 34522183
[No Abstract] [Full Text] [Related]
13. Hospitalization risk among adults with bipolar I disorder treated with lurasidone versus other oral atypical antipsychotics: a retrospective analysis of Medicaid claims data.
Niu X; Veeranki P; Dennen S; Dembek C; Laubmeier K; Liu Y; Williams GR; Loebel A
Curr Med Res Opin; 2021 May; 37(5):839-846. PubMed ID: 33682547
[TBL] [Abstract][Full Text] [Related]
14. Comparative safety of atypical antipsychotics and the risk of pneumonia in the elderly.
Mehta S; Pulungan Z; Jones BT; Teigland C
Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1271-80. PubMed ID: 26445931
[TBL] [Abstract][Full Text] [Related]
15. Risk of pneumonia in elderly nursing home residents using typical versus atypical antipsychotics.
Aparasu RR; Chatterjee S; Chen H
Ann Pharmacother; 2013 Apr; 47(4):464-74. PubMed ID: 23548651
[TBL] [Abstract][Full Text] [Related]
16. Health care resource utilization patterns among patients with Parkinson's disease psychosis: analysis of Medicare beneficiaries treated with pimavanserin or other-atypical antipsychotics.
Rajagopalan K; Rashid N; Kumar S; Doshi D
J Med Econ; 2023; 26(1):34-42. PubMed ID: 36444507
[TBL] [Abstract][Full Text] [Related]
17. Medication Adherence, Health Care Utilization, and Costs in Patients With Major Depressive Disorder Initiating Adjunctive Atypical Antipsychotic Treatment.
Broder MS; Greene M; Yan T; Chang E; Hartry A; Yermilov I
Clin Ther; 2019 Feb; 41(2):221-232. PubMed ID: 30616973
[TBL] [Abstract][Full Text] [Related]
18. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
19. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
20. Healthcare resource utilization among nursing home residents with Parkinson's disease psychosis: an analysis of Medicare beneficiaries treated with pimavanserin or other-atypical antipsychotics.
Rajagopalan K; Rashid N; Gopal D; Doshi D
J Comp Eff Res; 2024 Jul; 13(7):e240038. PubMed ID: 38850129
[No Abstract] [Full Text] [Related]
[Next] [New Search]
